drugset
drugset / Trial / NCT01520896

Study in Healthy Volunteers to Investigate the Effects of Ketoconazole on the Pharmacokinetics of NKTR-118

NCT01520896 ↗

Phase 1 Completed 22 enrolled AstraZeneca
Non-randomizedCrossoverOpen-labelBasic science

Summary

Study in healthy volunteers to investigate the effects of Ketoconazole on the Pharmacokinetics of NKTR-118

Timeline

Start
2012-02
Primary completion
2012-04
Completion
2012-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketoconazole Small molecule 400 mg Oral
Subject Naloxegol Small molecule 25 mg Oral

Indications

No indication recorded.